Business Context and Reporting Period
This Form 8-K is a Current Report filed by Viewbix Inc. (not Quantum X Labs Inc.) on July 11, 2025, regarding events occurring on that date and the closing of a transaction on July 14, 2025. The company is incorporated in Delaware and headquartered in Tel Aviv, Israel. The filing details the entry into a Material Definitive Agreement for a private placement of equity securities.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $4.5 million expected from the initial private placement.
- Potential Additional Proceeds: Up to $4.4 million if all warrants are exercised in cash.
- Securities Issued:
- 848,763 shares of Common Stock.
- Pre-Funded Warrants to purchase up to 77,160 shares.
- Common Warrants to purchase up to 925,923 shares.
- Offering Price: $4.86 per Private Placement Share and associated Common Warrant; $4.8599 per Pre-Funded Warrant and associated Common Warrant.
- Transaction Costs: A cash placement fee of 7.0% of gross proceeds plus $50,000 for legal fees payable to Aegis Capital Corp.
- Warrant Terms: Common Warrants have an exercise price of $4.74 per share and expire 5.5 years from issuance. Pre-Funded Warrants are immediately exercisable at $0.0001.
Note: This filing does not provide standard financial metrics such as revenue, net profit, operating cash flow, margins, or total debt levels.
Material Changes
The primary material change is the capital raise via a private placement offering. The company has increased its share count and issued new warrants, which may result in dilution to existing shareholders. The transaction closed on July 14, 2025, following the signing of the Purchase Agreement on July 11, 2025.
Guidance, Outlook, and Risks
- Registration Rights: The company must file a resale registration statement within 14 trading days of the signing date and have it declared effective within 60 to 90 days, depending on SEC review.
- Standstill Restrictions: The company agreed to customary standstill restrictions for 30 days following the later of the closing date or the effectiveness of the registration statement.
- Forward-Looking Statements: The filing includes standard warnings that forward-looking statements are not guaranteed and are subject to risks and uncertainties.
- Unregistered Securities: The securities were sold under Section 4(a)(2) of the Securities Act of 1933 and are not registered, limiting their resale until a registration statement is effective.
Investor Verification Checklist
- Verify the final closing amount and net proceeds after deducting the 7% placement fee and legal expenses.
- Confirm the filing date and effectiveness status of the resale registration statement required under the Registration Rights Agreement.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and redemption rights.
- Assess the potential dilution impact of the 925,923 Common Warrants and 77,160 Pre-Funded Warrants on existing shareholders.
- Check subsequent filings for the company's use of the raised capital and any updates to its financial position.